[1] Sheenchen SM, Sun CK, Liu YW, et al. Extremely elevated CA19-9 in acute cholangitis. Dig Dis Sci, 2007, 52:3140-3142.
[2] Singh Saluja S, Sharma R, Pal S, et al. Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study. HPB(Oxford), 2007, 9:373-382.
[3] La GG, Sofia M, Lombardo R, et al. Adjusting CA19-9 values to predict malignancy in obstructive jaundice: influence of bilirubin and C-reactive protein. World J Gastroenterol, 2012, 18:4150-4155.
[4] 邓辉洲, 周载平, 陈宏,等. 阻塞性胆道疾病中血清CA199水平分 析. 中华普通外科学 文献:电子版, 2008, 2:46-47.
[5] Yuksel BC, Yildiz Y, Ozturk B, et al. Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis. Am J Surg, 2008, 195:452-456.
[6] Murohisa T, Sugaya H, Tetsuka I, et al. A case of common bile duct stone with cholangitis presenting an extraordinarily high serum CA19-9 value. Int Med, 1992, 31:516-520.
[7] 梅永, 彭慈军, 陈丽,等. 血清CA19-9早期预判梗阻性黄疸发生急 性胆管炎临床价值研究.中国实用外科杂志, 2015, 35:445-447.
[8] 杨天文, 何平. 胆结石患者血清CA19-9、CEA表达与胆管炎症的 关系. 重庆医学, 2013, 42:633-634. |
